Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07008664 · ClinicalTrials.gov registry record
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
A clinical trial of Lung Cancer and Lung Cancer Screening, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT07008664 is a study of Lung Cancer and Lung Cancer Screening that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 750 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07008664, a study of Lung Cancer and Lung Cancer Screening, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.
Conditions Studied
Interventions
- OTHER Epigenetic Signature Assay
Study Locations (1)
Maryland
- University of Maryland Baltimore Washington Medical Center - Glen Burnie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2032-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07008664
The ClinicalTrials.gov registry entry for NCT07008664 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (20% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Epigenetic Signature Assay is the first listed.
NCT07008664 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT07008664 about?
NCT07008664 is a clinical study titled "Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer". The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood sample...
What is the current status of trial NCT07008664?
This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2025-03-31. Estimated completion is 2032-04.
What conditions does trial NCT07008664 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Cancer Screening, Healthy Volunteers (HV), Unhealthy Volunteers.
What interventions are being tested in trial NCT07008664?
The interventions under investigation include: Epigenetic Signature Assay (OTHER).
Who is sponsoring clinical trial NCT07008664?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07008664 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.